Please note that slides are for review only and not to be repurposed or published.

Dissecting the Decision: Investigators Discuss Emerging Treatment Strategies and Novel Approaches in Gynecologic Cancers | Part 1 of 2-Part Series

Investigator Survey

MODULE 1:
Selection and Sequencing of Available Therapies for Patients with Ovarian Cancer — Dr Monk

MODULE 2:
Current Systemic Treatment of Advanced Cervical Cancer and Endometrial Cancer — Dr Secord

MODULE 3:
Novel Investigational Agents in Development and Emerging Role of Immunotherapy in Gynecologic Cancers — Dr Birrer

Existing and Emerging Strategies in the Management of Patients with Uterine Sarcomas

MODULE 1:
Current Management of Localized Uterine Leiomyosarcoma — Dr Miller

MODULE 2:
Available and Emerging Novel Systemic Agents in the Treatment of Metastatic Disease — Dr Van Tine

MODULE 3:
Sequencing of Systemic Agents in the Treatment of Metastatic Disease — Dr Monk

Dissecting the Decision: Investigators Discuss PARP Inhibition in the Management of Ovarian Cancer | Part 2 of a 2-Part Series

MODULE 1:
Genomic Assessment in the Treatment of Ovarian Cancer — Dr Penson

MODULE 2:
PARP Inhibitor Monotherapy in Advanced Disease — Dr Matulonis

MODULE 3:
Published and Emerging Research Data with PARP Inhibitor Maintenance Therapy — Dr Ledermann

MODULE 4:
Unique Tolerability Considerations Associated with PARP Inhibitors — Dr Coleman